Si, Stephanie J. http://orcid.org/0000-0001-5983-581X
Tasian, Sarah K.
Bassiri, Hamid
Fisher, Brian T.
Atalla, Jasmyn
Patel, Reema
Romberg, Neil
Lambert, Michele P.
Paessler, Michele
Behrens, Edward J.
Teachey, David T.
Sullivan, Kathleen E.
Article History
Received: 16 November 2020
Accepted: 15 March 2021
First Online: 24 March 2021
Declarations
:
: Not applicable.
: Not applicable.
: Yes, we consent for publication.
: SKT receives research funding from Incyte Corporation and Gilead Sciences for unrelated studies and serves on the scientific advisory board of Aleta Biotherapeutics. HB is an owner of CSL Behring stock and is a consultant for Kriya Therapeutics. MPL is an advisory board member for Octapharma and Shionogi, is a consultant for Amgen, Novartis, Shionogi, Dova, Principia, Argenx, Rigel, and Bayer, and has received research funding from Sysmex, Novartis, Rigel, and Astra Zeneca. DTT serves on advisory boards for Amgen, La Roche, Janssen, and Sobi. BTF’s institution receives funding from Merck and Pfizer for research studies, and he also serves on a Data Safety Monitoring Committee for Astellas. These studies are not related to this project. The remaining authors declare no relevant conflicts of interest.
Free to read: This content has been made available to all.